Company / Total Assets
Solid Biosciences Inc. Total Assets History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$260.3M
FY2022
5-year range
$103.5M / $260.3M
FY2018-FY2022
Trend
+12.0%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets has increased for 3 consecutive years, from $103M in FY2019 to $260M in FY2022.
Based on SEC 10-K filings.
$260M in FY2022 with a 3-year CAGR of +36.0%.
Improved from $171M to $260M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- +36.0%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Solid Biosciences Inc.'s total assets has grown for 3 consecutive years.
- 3-year CAGR of +36.0%, indicating consistent growth.
- In FY2022, total assets increased 12.0% year-over-year.
- Lowest total assets in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $260.3M | +12.0% |
| FY2021 | $232.4M | +35.8% |
| FY2020 | $171.2M | +65.4% |
| FY2019 | $103.5M | -25.9% |
| FY2018 | $139.6M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026